Economy News Why Weight Loss Drugs Like Ozempic Are A Game Changer For The Global Economy

Are Weight Loss Drugs About to Get Less Expensive?

That said, GLP-1 medications for weight loss are not for everyone, and they can cause unpleasant, even serious, side effects, including gastrointestinal issues like nausea and diarrhea, and ... Read More

GLP-1 drugs like Ozempic deliver huge weight loss but new research reveals a hidden catch

GLP-1 drugs like tirzepatide and semaglutide offer powerful weight-loss effects but come with unanswered questions about long-term safety, side effects, and global accessibility. Researchers stress ... Read More

Weight-loss drugs like Ozempic may also curb drug and alcohol addiction

GLP-1 drugs, originally developed for diabetes and obesity, may also curb addictive behaviors by acting on reward circuits in the brain. Early trials show reductions in alcohol intake, opioid seeking, ... Read More

Novo Nordisk Just Made a Big Move in the Weight Loss Drug Market. Should You Worry About Rival Eli Lilly?

Eli Lilly's tirzepatide acts on two hormonal pathways, so it's called a dual GIP/GLP-1 receptor agonist, and it entered the market as Mounjaro for Type 2 diabetes and as Zepbound for weight management ... Read More

Ozempic’s Latest Weight Loss Competition Is Like Nothing We’ve Seen Before

The race to develop the next generation of weight loss drugs has taken an interesting new turn. In recent research, Eli Lilly’s experimental treatment eloralintide helped people lose a substantial ... Read More

Trump says Medicare can now cover weight loss drugs like Ozempic

Medicare will cover weight-loss drugs under a deal between the Trump administration and drugmakers Eli Lilly and Novo Nordisk to cut prices for blockbuster diabetes and anti-obesity drugs. Why it ... Read More

Weight loss drugs are bringing down the country's obesity rate, a survey shows

The number of people using injectable obesity treatments is increasing rapidly, and it is leading to declines in obesity, according to a new survey by the Gallup National Health and Well-Being Index. Read More

Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount

Novo launched a rival bid to acquire American obesity biotech firm Metsera last week, superseding an offer for the firm from U.S. pharma giant Pfizer. On Monday, Pfizer said it had filed a second ... Read More

Popular weight-loss drugs could take the edge off your alcohol buzz, study finds

Popular drugs credited with shrinking waistlines and controlling blood sugar may also take the edge off alcohol’s buzz, according to a new study. Researchers at Virginia Tech's Fralin Biomedical ... Read More

Muscle loss from GLP-1 drugs like Ozempic may not be as high as thought

While past studies show that adults taking a GLP-1 medication can lose between 5-15% of their starting body weight, other research reports that a good portion of that weight loss comes from muscle ... Read More

Trump Negotiating Deal With Ozempic Maker to Sell Some Weight-Loss Drugs for $149

The Trump administration is negotiating a deal with weight-loss drugmakers Eli Lilly LLY-0.17%decrease; red down pointing triangle and Novo Nordisk NOVO.B-0.03%decrease; red down pointing triangle ... Read More

Eli Lilly partners with Walmart to sell weight loss drug directly to patients nationwide

Patients will be able to access Eli Lilly's weight loss drug Zepbound at Walmart pharmacies nationwide through its direct-to-consumer program as soon as next month. The partnership between Eli Lilly ... Read More